-
Hind.Aeronautics
4,294.00 5,675.00(%) -
Zomato Ltd
200.50 146.85(%) -
Aster DM Health.
504.00 558.30(%) -
Reliance Industr
1,269.05 1,156.00(%) -
Tata Motors
684.90 1,179.05(%) -
Jio Financial
232.25 394.70(%) -
Mazagon Dock
2,635.55 920.48(%) -
Vodafone Idea
6.77 6.60(%) -
HDFC Bank
1,836.40 1,880.00(%) -
Suzlon Energy
56.40 37.95(%) -
M & M
2,635.10 1,872.45(%) -
IDFC First Bank
54.63 52.60(%) -
Dixon Technolog.
13,019.00 7,100.05(%) -
I R F C
123.65 108.05(%) -
Bharat Electron
306.50 340.35(%) -
Adani Energy Sol
863.60 588.25(%) -
Asian Paints
2,322.35 2,125.00(%) -
Reliance Power
44.75 54.25(%) -
Hindustan Copper
218.75 195.35(%) -
IndusInd Bank
643.70 605.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 3135.0
- ISIN : INE191A01027
-
Today’s Low
772.20 -
Today’s High
815.95

-
Open
785.00 -
Perv Close
777.10 -
52W Low
761.10 -
52W High
1,997.40
Key Indicators
-
P/E(TTM)
35.23
-
Mar.Cap (₹Cr.)
3,936.31
-
Div & Yield %
0.00
-
Book Value(₹)
250.68
-
Debt-Equity Ratio
-0.13
-
AGM Date
28-Mar-2025
-
EPS
22.05
-
P/E Ratio
35.23
Financials Ratios
-
Debt-Equity Ratio
0.25
-
Mar.Cap (₹Cr.)
3,936.31
-
RONW (%)
3.02
-
ROCE (%)
3.20
Score Board
-
Equity (₹ in Cr.)
50.72
-
BV (₹)
250.70
-
Sales( ₹ in Cr.)
819.37
-
NP (in Cr.)
94.94
-
NP Var(%)
569.0
-
Div%
0.0
-
CPS (₹)
25.30
-
EPS (₹)
18.70
-
Traded Value (₹ in Lakhs)
3,940.37
-
52 Week High
1,997.40
-
52 Week Low
761.10
-
Price BSE
777.0
-
Price NSE
776.00
-
Market Capital( in Cr.)
3,940.37
-
P/C Ratio
30.80
-
P/E Ratio
41.50
-
Price Vs.BV
18.70
-
07-Mar-2025( 01:33)
Corporate News - Orchi... - Orchid Pharma announced that C...
-
19-Feb-2025( 07:36)
Corporate News - Orchi... - <P>Orchid Pharma announced the...
-
12-Feb-2025( 05:53)
Results - Announcements - Orchi... - Net profit of Orchid Pharma de...
-
07-Feb-2025( 03:56)
Corporate News - Orchi... - Orchid Pharma will hold a meet...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 819.37 | 665.90 | 556.97 | 450.70 | 481.21 | 583.65 |
Excise Duty | 815.12 | 655.61 | 553.49 | 438.82 | 462.69 | 536.87 |
Net Sales | 819.37 | 665.90 | 556.97 | 450.70 | 481.21 | 583.65 |
Other Income | 30.39 | 19.43 | 9.00 | 6.46 | 24.28 | 16.93 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 849.76 | 685.33 | 565.98 | 457.16 | 505.49 | 600.57 |
EXPENDITURE : | ||||||
Raw Materials | 815.12 | 655.61 | 553.49 | 438.82 | 462.69 | 536.87 |
Power & Fuel Cost | 815.12 | 655.61 | 553.49 | 438.82 | 462.69 | 536.87 |
Employee Cost | 69.64 | 65.35 | 60.21 | 64.40 | 71.60 | 79.14 |
Other Manufacturing Expenses | 5.84 | 6.90 | 8.67 | 3.97 | 52.98 | 100.03 |
Selling & Administrative Expenses | 69.42 | 49.42 | 50.08 | 42.94 | 75.49 | 65.73 |
Miscellaneous Expenses | 5.84 | 6.90 | 8.67 | 3.97 | 52.98 | 100.03 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 758.23 | 669.29 | 618.75 | 553.03 | 593.94 | 726.56 |
Operating Profit | 79.33 | 75.99 | 66.69 | 52.22 | 71.50 | 73.28 |
Interest | 16.33 | 32.23 | 32.01 | 51.34 | 4.16 | 0.30 |
Gross Profit | 91.52 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Depreciation | 33.22 | 54.79 | 87.02 | 108.90 | 117.91 | 129.92 |
Profit Before Tax | 91.52 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -3.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Net Profit | 94.75 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Extraordinary Items | 91.52 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Adjusted Net Profit | 94.75 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | -1.06 | 47.96 | -21.28 | -61.38 | 0.00 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 94.75 | 55.25 | -52.77 | -95.87 | -88.46 | -101.05 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 19.59 | 13.28 | -1.18 | -28.70 | -16.87 | -11.36 |
Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book Value(Adj)-Unit Curr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |